Copyright
©2010 Baishideng. All rights reserved.
World J Hepatol. Jun 27, 2010; 2(6): 239-242
Published online Jun 27, 2010. doi: 10.4254/wjh.v2.i6.239
Published online Jun 27, 2010. doi: 10.4254/wjh.v2.i6.239
Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib
Christoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, Nicole do O, Tom Ludde, Christian Trautwein, Jens J Tischendorf, Department of Medicine III, University of Aachen (RWTH), Pauwelstraße 30, Aachen 52074, Germany
Andreas Mahnken, Department of Radiology, University of Aachen (RWTH), Pauwelstraße 30, Aachen 52074, Germany
Author contributions: Roderburg C, Bubenzer J, Spannbauer M, do O N, Mahnken A, Ludde T, Trautwein C, and Tischendorf JJ designed research; Roderburg C, Mahnken A, and Tischendorf JJ performed research; Roderburg C, Mahnken A, Ludde T, and Tischendorf JJ analyzed data; and Roderburg C, Bubenzer J, Spannbauer M, do O N, Mahnken A, Ludde T, Trautwein C, and Tischendorf JJ wrote the paper.
Supported by “Bayer AG”
Correspondence to: Christoph Roderburg, MD, Department of MedicineIII, University of Aachen, Pauwelstraße 30, Aachen 52074, Germany. croderburg@ukaachen.de
Telephone: +49-241-8035367 Fax: +49-241-8082107
Received: February 4, 2010
Revised: May 4, 2010
Accepted: May 11, 2010
Published online: June 27, 2010
Revised: May 4, 2010
Accepted: May 11, 2010
Published online: June 27, 2010
Core Tip